Vivo Bio Tech Limited Opens Special Window for Physical Share Transfer
Vivo Bio Tech Limited has opened a special window for physical share transfer and dematerialisation from February 05, 2026 to February 04, 2027, following SEBI guidelines. The facility is available for investors who purchased shares before April 01, 2019 and either hadn't lodged transfer requests or had previous requests rejected due to documentation issues.

*this image is generated using AI for illustrative purposes only.
Vivo Bio Tech Limited has issued a comprehensive newspaper notice to inform shareholders about a special window for physical share transfer and dematerialisation. The biotechnology company, headquartered in Hyderabad, has announced this initiative to assist shareholders in meeting regulatory requirements pursuant to SEBI guidelines.
Special Window for Physical Share Transfer
Pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, the company has opened a special window for shareholders to facilitate transfer and dematerialisation requests for physical securities. This initiative addresses specific regulatory requirements for legacy shareholdings.
| Parameter: | Details |
|---|---|
| Window Period: | February 05, 2026 to February 04, 2027 |
| Eligibility: | Securities purchased prior to April 01, 2019 |
| Requirement: | Original share certificate must be available |
| Processing: | Transfer requests will be processed in dematerialised form only |
The special window accommodates two categories of investors: those who had not lodged transfer of shares, and those who had lodged shares for transfer but were rejected, returned, or not attended to due to deficiencies in documentation.
Eligibility Matrix for Shareholders
The company has provided a clear eligibility matrix to help shareholders understand their qualification for the special window:
| Lodged for transfer before April 01, 2019? | Original share certificate available? | Eligible for special window? |
|---|---|---|
| No, fresh lodgement: | Yes | Yes (subject to SEBI circular conditions) |
| Yes, rejected/returned earlier: | Yes | Yes (subject to SEBI circular conditions) |
| Yes, was lodged: | No | No |
| No, was not lodged: | No | No |
Registrar and Transfer Agent Information
Shareholders are directed to contact the company's appointed Registrar and Share Transfer Agent for all transfer-related activities:
Aarthi Consultants Private Limited
- Unit: Vivo Bio Tech Limited
- Address: 1-2-285, Domalguda, Hyderabad - 500029, Telangana, India
- Phone: 040-27638111
- Email: info@aarthiconsultants.com
Documentation Requirements
The company has specified that only requests accompanied by original share certificates along with transfer deeds and other supporting documents will be considered under the special window. Shareholders must submit their applications within the stipulated period to avail of this facility.
For further details, investors may refer to the SEBI circular available on the regulator's official website. The notice was signed by A V Kiran, Company Secretary, and published on April 06, 2026. This initiative demonstrates the company's commitment to regulatory compliance and shareholder service enhancement.
Historical Stock Returns for Nahar Capital & Financial Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.12% | +0.58% | -3.68% | -23.43% | -6.75% | +109.05% |
Will SEBI extend similar special windows for other biotechnology companies with legacy shareholding issues?
How might this dematerialisation initiative impact Vivo Bio Tech's share liquidity and trading volumes?
What happens to unclaimed physical shares after the February 2027 deadline expires?





























